These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17192909

  • 21. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R.
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [Abstract] [Full Text] [Related]

  • 22. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.
    Razonable RR, van Cruijsen H, Brown RA, Wilson JA, Harmsen WS, Wiesner RH, Smith TF, Paya CV.
    J Infect Dis; 2003 Jun 01; 187(11):1801-8. PubMed ID: 12751039
    [Abstract] [Full Text] [Related]

  • 23. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH, Mor E, Brown M, Bar-Nathan N, Shaharabani E, Sulkes J, Pappo O, Tur-Kaspa R, Ben-Ari Z.
    Clin Transplant; 2006 Jun 01; 20(4):465-70. PubMed ID: 16842523
    [Abstract] [Full Text] [Related]

  • 24. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Jun 01; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 25. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 01; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 26. Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?
    Fujita S, Fujikawa T, Mizuno S, Reed AI, Kim RD, Howard RJ, Firpi RJ, Nelson DR, Hemming AW.
    Transplantation; 2007 Dec 27; 84(12):1631-5. PubMed ID: 18165775
    [Abstract] [Full Text] [Related]

  • 27. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
    Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.
    Liver Transpl; 2007 May 27; 13(5):687-92. PubMed ID: 17457911
    [Abstract] [Full Text] [Related]

  • 28. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May 27; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 29. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G, Dhooge C.
    Transpl Infect Dis; 2008 Feb 27; 10(1):19-23. PubMed ID: 17511814
    [Abstract] [Full Text] [Related]

  • 30. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 27; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 31. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F, Di Sandro S, De Ruvo N, Berretta M, Montalti R, Guerrini GP, Ballarin R, De Blasiis MG, Spaggiari M, Smerieri N, Iemmolo RM, Guaraldi G, Gerunda GE.
    Transplant Proc; 2008 Jan 27; 40(6):1965-71. PubMed ID: 18675102
    [Abstract] [Full Text] [Related]

  • 32. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL.
    Liver Transpl; 2009 Jul 27; 15(7):754-62. PubMed ID: 19562709
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
    Bayram A, Ozkur A, Erkilic S.
    J Clin Virol; 2009 Jul 27; 45(3):212-7. PubMed ID: 19497785
    [Abstract] [Full Text] [Related]

  • 34. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ.
    Liver Transpl; 2005 Oct 27; 11(10):1207-13. PubMed ID: 16184568
    [Abstract] [Full Text] [Related]

  • 35. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH.
    Eur J Gastroenterol Hepatol; 2008 Aug 27; 20(8):778-83. PubMed ID: 18617783
    [Abstract] [Full Text] [Related]

  • 36. The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.
    Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK.
    Transplantation; 2000 Nov 27; 70(10):1454-8. PubMed ID: 11118089
    [Abstract] [Full Text] [Related]

  • 37. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun 27; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 38. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
    Sharma P, Marrero JA, Fontana RJ, Greenson JK, Conjeevaram H, Su GL, Askari F, Sullivan P, Lok AS.
    Liver Transpl; 2007 Aug 27; 13(8):1100-8. PubMed ID: 17377914
    [Abstract] [Full Text] [Related]

  • 39. Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients.
    Saito T, Egawa H, Kudo T, Takakura S, Fujihara N, Iinuma Y, Ichiyama S.
    Transpl Int; 2007 May 27; 20(5):419-24. PubMed ID: 17313448
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.